25. Juli 2025|
AI
|4 months agoRoche CEO: Direct Sales Could Halve US Drug Prices
Roche's chief executive proposes cutting out intermediaries to reduce US drug prices by 50%, highlighting Swiss pharma's role in global healthcare costs debate.
AI
Generated IllustrationKey Takeaways
AI
- Roche CEO Thomas Schinecker proposes that US drug prices could be cut by 50% by selling directly to patients.
- President Trump has signed an executive order proposing a 'Most Favoured Nation' drug pricing policy.
- Roche plans to invest $50 billion in the US in manufacturing and R&D.
- Roche reported first-half sales of CHF 30.9 billion, a 7% increase at constant exchange rates.
By The Numbers
50%
Potential price reduction
2.3 times
Price disparity
CHF 30.9 billion
H1 Sales
200%
Potential Tariff Rate
They Said
"So if the US would like to cut prices by 50%, it’s very easy. We go direct."
"We hope that the US government, then also sees... that the companies are intending to produce the medicines that are needed in the US, for the US."
1
Slashing Prices: The Direct-Sales Ultimatum
2
The Middleman Trap: Zero Risk, Maximum Cost
3
Navigating Trump's Tariff Minefield
4